{
  "docId": "019de075-60f4-719a-882e-3143e28b60e4",
  "docSlug": "fdbc224a3aaf8eece0f490c97a32599d",
  "documentTitle": "MAIA Biotechnology | Investor Presentation Deck | 35 slides",
  "authorId": "maia-biotechnology",
  "authorName": "MAIA Biotechnology",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-07-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 35,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "traction",
  "function": "show_traction",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": "Slide highlights a strategic partnership/validation event.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-60f4-719a-882e-3143e28b60e4/11",
  "deckHref": "/decks/019de075-60f4-719a-882e-3143e28b60e4",
  "deckJsonHref": "/decks/019de075-60f4-719a-882e-3143e28b60e4.json",
  "deckAnchorHref": "/decks/019de075-60f4-719a-882e-3143e28b60e4#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.25,
        "w": 0.92,
        "x": 0.04,
        "y": 0.21
      },
      "kind": "image",
      "text": "MAIA Biotechnology & Regeneron logos",
      "attrs": null,
      "subkind": "logo-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7a00cb0d-b20c-4133-8f7e-7af549294d09",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.35,
        "w": 0.86,
        "x": 0.07,
        "y": 0.5
      },
      "kind": "paragraph",
      "text": "Feb 2, 2021\nMAIA Biotechnology, Inc. Announces Clinical Supply Agreement with Regeneron for Phase 1/2 Clinical Trial Evaluating THIO in Sequential Administration with Libtayo® (cemiplimab) in Advanced Non-Small Cell Lung Cancer",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2e84aeb9-6e55-4ce7-9261-fa46e82943f8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "REGENERON AGREEMENT",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab2ff86f-6fa0-49b9-a131-c2a633e11635",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 12,
      "from": 8,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "b33f6867-01cb-4462-9e1a-0004be744e1a",
      "evidence": "The loop is opened on slide 8 and closed on slide 12, discussing the current state of clinical development and the potential for THIO",
      "position": 1,
      "objective": "Why is now the right time for THIO?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}